Details for Patent: 10,231,931
✉ Email this page to a colleague
Which drugs does patent 10,231,931 protect, and when does it expire?
Patent 10,231,931 protects LEVOLET and is included in one NDA.
Summary for Patent: 10,231,931
| Title: | Thyroid hormone oral dosage forms and methods of using the same |
| Abstract: | Novel thyroid hormone oral dosage forms and methods of making and using the thyroid hormone oral dosage forms are disclosed. |
| Inventor(s): | Phadke; Shivaji (Berkeley Heights, NJ), Parikh; Vaishnavi (Sellersville, PA) |
| Assignee: | GENUS LIFESCIENCES INC. (Allentown, PA) |
| Application Number: | 15/934,185 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 10,231,931
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-003 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-004 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-005 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-006 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
